Microsure Revenue and Competitors
Estimated Revenue & Valuation
- Microsure's estimated annual revenue is currently $15.6M per year.
- Microsure's estimated revenue per employee is $251,000
Employee Data
- Microsure has 62 Employees.
- Microsure grew their employee count by 5% last year.
Microsure's People
Name | Title | Email/Phone |
---|---|---|
1 | Chief Technology Officer | Reveal Email/Phone |
2 | Director Software Development | Reveal Email/Phone |
3 | Manufacturing Engineer | Reveal Email/Phone |
4 | Associate Control Engineer | Reveal Email/Phone |
Microsure Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $6.1M | 49 | -18% | $10M | N/A |
#2 | $30.4M | 121 | 29% | N/A | N/A |
#3 | $139.8M | 913 | -3% | $200K | N/A |
#4 | $84.1M | 0 | N/A | $1.2M | N/A |
#5 | $43.4M | 173 | 30% | N/A | N/A |
#6 | $64.5M | 257 | 12% | N/A | N/A |
#7 | $64.3M | 205 | 26% | $129.6M | N/A |
#8 | $19.6M | 78 | -7% | N/A | N/A |
#9 | $65.8M | 262 | 7% | N/A | N/A |
#10 | $73.7M | 235 | 20% | $115.5M | N/A |
What Is Microsure?
Microsure is a medical device company located in Eindhoven (Netherlands) founded by Eindhoven University of Technology and Maastricht University Medical Center in 2016. Our focus is to improve patient's lives through developing robot systems for microsurgery. Our current product is MUSA, the world's first surgical robot for open microsurgery. MUSA is designed in close cooperation with microsurgeons and engineers, specifically for microsurgical applications. MUSA provides superhuman precision for microsurgeons, enabling new interventions that are currently impossible to perform by hand.
keywords:N/AN/A
Total Funding
62
Number of Employees
$15.6M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $17.3M | 63 | -7% | N/A |
#2 | $20.5M | 90 | -35% | N/A |
#3 | $56.6M | 107 | 32% | N/A |
#4 | $17.8M | 123 | 34% | N/A |
#5 | $16M | 145 | 12% | N/A |